Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study

INTRODUCTION: Patients with differentiated thyroid cancer (DTC) are treated with (near)-total thyroidectomy followed by remnant ablation. Optimal radioiodine-131 ((131)I) uptake is achieved by withholding thyroid hormone (THW), pretreatment with recombinant human Thyrotropin Stimulating Hormone (rhT...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: van der Horst-Schrivers, Anouk N. A., Sluiter, Wim J., Muller Kobold, Anneke C., Wolffenbuttel, Bruce H. R., Plukker, John T. M., Bisschop, Peter H., de Klerk, John M., Al Younis, Imad, Lips, Paul, Smit, Jan W., Brouwers, Adrienne H., Links, Thera P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367989/
https://ncbi.nlm.nih.gov/pubmed/25793762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120184
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi